— A weekly roundup of healthcare investigations
June 24, 2026
• 2 min read
Despite political warnings and legal challenges, there's still a push to keep HHS Secretary Robert F. Kennedy Jr.'s vaccine agenda alive -- but it has shifted largely out of public view. Kennedy allies are "embedding his agenda" at institutions, deciding what gets studied, who undertakes vaccine research, and how findings are translated into policy. (Washington Post)
New York health officials accused Tiger Medical Holdings of "smuggling" a popular new injectable filler into the state. It has seen a surge in demand for alloClae, its product derived from the fat of dead people. While the company said the FDA doesn't require premarket approval for the product, New York requires permission to store and distribute human tissue, which the company allegedly does not have. (Business Insider)
